Bebia Z, Reyes O, Jeanfreau R, Kantele A, et al. Safety and immunogenicity of an investigational respiratory syncytial virus vaccine (RSVPreF3) in mothers and their infants: a phase 2 randomized trial. J Infect Dis 2023 Feb 1:jiad024. doi: 10.1093.
PMID: 36722147